Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation

被引:16
作者
Desanctis, LB
Stefoni, S
Cianciolo, G
Coli, L
Buscaroli, A
Feliciangeli, G
Borgnino, LC
Bonetti, M
Gregorini, MC
DeGiovanni, P
Buttazzi, R
机构
[1] UNIV BOLOGNA, S ORSOLA M MALPIGHI HOSP, INST NEPHROL, BOLOGNA, ITALY
[2] UNIV BOLOGNA, S ORSOLA M MALPIGHI HOSP, CENT LAB, BOLOGNA, ITALY
关键词
biocompatibility; platelet; dialysis membranes; cuprophan; polysulfone; cellulose triacetate;
D O I
10.1177/039139889601900705
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Intradialytic coagulative and platelet activation, one of the main consequences of blood-membrane contact, was studied in a group of 5 RDT patients with a comparative evaluation of 3 different dialytic membranes: Cuprophan (CU), Polysulfone (PS) and Cellulose Triacetate (CT). Each patient underwent 5 consecutive dialysis sessions with the above mentioned membranes. Intradialytic platelet activation was studied through a morpho-functional evaluation between the mean platelet volume (MPV) and Serotonin (S), beta-Thromboglobulin (beta-TG) and Platelet Factor 4 (PF4) serum levels. These determinations were made before HD (time 0) and after 30', 120' and 240'. We also checked the intradialytic status of thrombogenesis and fibrinolysis determining aPTT, thrombin time fibrinogen, antithrombin III (AT III), alpha-2 antiplasmin and plasminogen, af the same time intervals. Ail membranes tested (CU, PS, CT) caused appreciable intradialytic platelet activation, above all after 15' and at the end of dialysis sessions, more marked for CU than PS or CT in particular MPV showed a decrease throughout the session (-5% at 30' and -9% at 240') while S, beta TG and PF4 peripheral blood levels showed a significant increase at the same intervals with CU membrane. Lastly coagulative and fibrinolytic parameters showed no significant differences among any of the membranes tested.
引用
收藏
页码:404 / 410
页数:7
相关论文
共 33 条
[11]  
COLI L, 1989, EMODIAFILTRAZIONE ED, P161
[12]   PHARMACODYNAMICS, CLINICAL INDICATIONS, AND ADVERSE-EFFECTS OF HEPARIN [J].
FREEDMAN, MD .
JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (07) :584-596
[13]   FULL AUTOMATION OF SEROTONIN DETERMINATION BY COLUMN-SWITCHING AND HPLC [J].
GROSSI, G ;
BARGOSSI, A ;
SPROVIERI, G ;
BERNAGOZZI, V ;
PASQUALI, R .
CHROMATOGRAPHIA, 1990, 30 (1-2) :61-68
[14]  
KAPLAN KL, 1981, BLOOD, V57, P199
[15]   WHOLE-BLOOD SEROTONIN LEVELS ARE MARKEDLY ELEVATED IN PATIENTS ON DIALYTIC THERAPY [J].
KERR, PG ;
ARGILES, A ;
MION, C .
AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (1-2) :14-18
[16]  
LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
[17]  
LINDSAY RM, 1977, J LAB CLIN MED, V89, P724
[18]  
MALMGREN R, 1979, HAEMOSTASIS, V8, P400
[19]  
MALO AM, 1993, KIDNEY INT S, V41, pS213
[20]  
MOHAMAD SF, 1986, T AM SOC ART INT ORG, V23, P323